The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-07), Journey Medical's share price is $3.59. Journey Medical's Book Value per Share for the quarter that ended in Dec. 2023 was $1.05. Hence, Journey Medical's PB Ratio of today is 3.41.
The historical rank and industry rank for Journey Medical's PB Ratio or its related term are showing as below:
DERM'
s PB Ratio Range Over the Past 10 Years
Min: 0.8 Med: 2.13 Max: 8.48
Current: 3.42
During the past 5 years, Journey Medical's highest PB Ratio was 8.48. The lowest was 0.80. And the median was 2.13.
DERM's PB Ratio is ranked worse than 71.85% of 959
companies
in the Drug Manufacturers industry
Industry Median: 2.02
vs DERM: 3.42
During the past 12 months, Journey Medical's average Book Value Per Share Growth Rate was 10.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -2.20% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Journey Medical was 78.90% per year. The lowest was -2.20% per year. And the median was 38.35% per year.
Back to Basics: PB Ratio
Journey Medical PB Ratio Historical Data
The historical data trend for Journey Medical's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Journey Medical's PB Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Journey Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Journey Medical's PB Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Journey Medical's PB Ratio distribution charts can be found below:
* The bar in red indicates where Journey Medical's PB Ratio falls into.
Journey Medical PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Journey Medical's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Journey Medical PB Ratio Related Terms
Thank you for viewing the detailed overview of Journey Medical's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Journey Medical (Journey Medical) Business Description
Journey Medical Corp is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm, etc.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DERM has been successfully added to your 